SANDOZ AMBRISENTAN TABLETS

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: d5ef0249080bc9e8
Drug Approval Canada Name: SANDOZ AMBRISENTAN TABLETS
Product Name: SANDOZ AMBRISENTAN TABLETS
Status: Marketed
Status Date: 2022-10-07
Original Market Date: 2022-10-07
Din: 02526875
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 48:48.00
Atc Original: C02KX02 AMBRISENTAN
Atc Name: c 02 kx 02
Aig Number: 0152452001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

AMBRISENTAN

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d5ef0249080bc9e8

Type

Standard